A Simple Rapid HPLC‐UV Method for Assessing C‐Terminal Arginine Content in Darbepoetin Alfa

Upon the development of biosimilar drugs, the structural, physical-chemical, and functional similarity to the original drug should be ensured. We have proposed a simple and rapid HPLC-UV method for assessing the content of C-terminal Arg<sup>166</sup> in darbepoetin alfa samples, in particular after their isolation from the culture fluid. All the stages of the described method (from the sample extraction to obtaining a chromatographic profile) take about 5 h. The proposed approach will be useful for laboratories developing a technology for producing recombinant darbepoetin alfa, to assess the quality of the product, and for subsequent optimization of the production process.

Authors

Institutions

Publication Details

Journal
Biomedical Chromatography
Published
2025-02-07
DOI
https://doi.org/10.1002/bmc.70018
Citations
1
Primary Topic
Biosimilars and Bioanalytical Methods
Type
article
Field-Weighted Citation Impact
0.80
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Simple Rapid HPLC‐UV Method for Assessing C‐Terminal Arginine Content in Darbepoetin Alfa

Dmitry Zybin, Д. В. Капустин, A. A. Klishin, Yu. A. Seregin et al.
1 citations
Biomedical Chromatography
Biosimilars and Bioanalytical Methods
0.80
article

A Simple Rapid HPLC‐UV Method for Assessing C‐Terminal Arginine Content in Darbepoetin Alfa

Dmitry Zybin, Д. В. Капустин, A. A. Klishin, Yu. A. Seregin, Н. В. Орлова, Tatiana S. Sorokina
article en
1 citations

Abstract

Upon the development of biosimilar drugs, the structural, physical-chemical, and functional similarity to the original drug should be ensured. We have proposed a simple and rapid HPLC-UV method for assessing the content of C-terminal Arg<sup>166</sup> in darbepoetin alfa samples, in particular after their isolation from the culture fluid. All the stages of the described method (from the sample extraction to obtaining a chromatographic profile) take about 5 h. The proposed approach will be useful for laboratories developing a technology for producing recombinant darbepoetin alfa, to assess the quality of the product, and for subsequent optimization of the production process.

Biomedical ChromatographyVol. 39(3)
SignPath Pharma (United States) (US), Institute of Bioorganic Chemistry (RU)
Industry, innovation and infrastructure
Openalex Percentile: Top 31%
Biosimilars and Bioanalytical Methods
0.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.